ECMO?

Rabia Yılmaz1, Murat Arslan1, Deniz Özel Bilgi1

  • 1University of Health Sciences Türkiye, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Anaesthesiology and Reanimation Critical Care, İstanbul, Türkiye.

概括

比瓦利鲁丁在体外膜氧化 (ECMO) 患者的抗凝剂中与未分离的肝素同样有效. 这项研究没有发现疗效差异,但比瓦利鲁丁的使用与更低的输血需求和更高的成本有关.